Novo Nordisk’s CagriSema outperformed the company’s flagship type 2 diabetes drug Ozempic (semaglutide) in both HbA1c levels and weight loss in a phase III trial. In the REIMAGINE 2 study (NCT06065540), CagriSema achieved a superior reduction in HbA1c of 1.91% points compared to 1.76% points with Ozempic after 68 weeks. CagriSema also led to a … Read more
There’s no denying the popularity of diet pills in the United States, with one in eight adults relying on GLP-1 to lose weight or treat a chronic condition, according to a November survey by the health policy organization KFF. The GLP-1 industry generates billions in revenue—and growing. The drugs, such as Ozempic and Wegovy, generated … Read more
Cheese is one of those foods that can be easy to overeat—and there’s a scientific reason for that. According to a study published in PLoS Onefoods high in carbohydrates and fat (such as cheese) can be addictive. Additionally, cheese contains a protein called casein that breaks down into opioid-like compounds and triggers a release of … Read more
Jelly Roll explained why he didn’t use GLP-1 before losing nearly 300 pounds on his weight loss journey. “I remember everyone telling me on GLP-1 or taking Ozempic or Mounjaro, ‘Listen, your stomach is going to hurt a little bit,’” Jelly Roll, 41, said in a new Men’s Health profile published Friday, Jan. 2. “I … Read more